NCT00778102 A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer. Status COMPLETED Phase PHASE2
NCT00759226 Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal Cancer Status COMPLETED Phase PHASE2
NCT00736944 Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00735345 Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma Status TERMINATED Phase PHASE2
NCT00591123 Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia Status COMPLETED Phase PHASE2
NCT00573131 Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer Status TERMINATED Phase PHASE2
NCT00502463 Induction Chemotherapy Prior to Radio-immunotherapy in Head and Neck Cancer Stage III/IV - a Methodical Trial Status COMPLETED Phase NA
NCT00501410 FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00468169 Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00433927 5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC) Status UNKNOWN Phase PHASE3
NCT00393068 Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer Status COMPLETED Phase PHASE2
NCT00392704 Treatment of Head & Neck Cancer With Chemotherapy and Radiation Status COMPLETED Phase PHASE2
NCT00349076 Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy With 5-Fluorouracil and Oxaliplatin Versus 5-Fluorouracil Alone in Rectal Cancer Status COMPLETED Phase PHASE3
NCT00316745 IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer Status SUSPENDED Phase PHASE3
NCT00289445 Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment) Status COMPLETED Phase PHASE1/PHASE2
NCT00235898 Clinical Trial in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00209690 Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer. Status COMPLETED Phase PHASE1/PHASE2
NCT00077233 FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum Status TERMINATED Phase PHASE3